Related Experiment Video
Updated: Jul 12, 2026

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Ricci Flow-Based Approach for Early Diagnosis of Alzheimer's Disease
Masoumeh Khodaei1,2, Behroz Bidabad3,4, Mohammad Ebrahim Shiri1
1Departartment of Mathematics and Computer Science, Amirkabir University of Technology, Tehran, Iran.
Neuroinformatics
|July 10, 2026
Summary
This study uses Ricci flow and Kernel LDA on MRI scans for early Alzheimer's disease (AD) detection. The novel method achieves high diagnostic accuracy, improving early detection of AD and related cognitive impairments.
Area of Science:
- Neuroimaging
- Medical Image Analysis
- Computational Geometry
Background:
- Early diagnosis of Alzheimer's disease (AD) is crucial due to its increasing prevalence and impact.
- Hippocampal atrophy is a key biomarker for AD, detectable via MRI.
- Advanced imaging and surface analysis techniques show promise for faster, more accurate AD diagnosis.
Purpose of the Study:
- To apply the Ricci flow method for mapping 3D hippocampal surfaces to a 2D sphere.
- To extract features for early AD detection using Linear Discriminant Analysis (LDA) and Kernel LDA.
- To evaluate the diagnostic performance of the developed model using the ADNI dataset.
Main Methods:
- MRI scans were preprocessed to isolate hippocampal surfaces.
- Ricci flow was used to map the 3D hippocampal surface to a 2D sphere.
- Feature vectors were constructed using LDA and Kernel LDA, followed by classification and model evaluation.
Main Results:
- Combining Ricci flow features with Kernel LDA significantly enhanced diagnostic accuracy for AD detection.
- High classification accuracies were achieved: 97.28% (NC/AD), 96.14% (NC/EMCI), 96.45% (NC/MCI), 94.83% (EMCI/LMCI), 95.84% (MCI/AD), and 95.37% (LMCI/AD).
- Three-way and four-way classification tasks yielded accuracies of 93.65% and 92.30%, respectively, outperforming many existing studies.
Conclusions:
- The integration of Ricci flow-based feature extraction with Kernel LDA offers a powerful approach for precise AD diagnosis.
- This method demonstrates significant potential for improving early detection of Alzheimer's disease and its prodromal stages.
- The findings underscore the value of advanced imaging and mathematical modeling in enhancing diagnostic precision for neurodegenerative diseases.
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
